This page is part of the Quality Measure STU2 for FHIR R4 Implementation Guide (v5.0.0-ballot2: STU5 (v5.0.0) Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 4.0.0. For a full list of available versions, see the Directory of published versions
Active as of 2022-02-22 |
Title: | EXM Measure | ||||
---|---|---|---|---|---|
Id: | EXM Measure | ||||
Version: | 2.0.0 | ||||
Url: | EXM Measure | ||||
EXM |
|||||
Effective Period: | 2018-01-01 ..2018-12-31 | ||||
Experimental: | true | ||||
Date: | 2022-02-22 | ||||
Publisher: | HL7 International / Clinical Quality Information | ||||
Author: | Example Measure Content Developer | ||||
Description: | An example FHIR-based measure |
||||
Use Context: |
|
||||
Jurisdiction: | US | ||||
Topic: | 57024-2 | ||||
Purpose: | The purpose of this measure is to show how all the elements of a FHIR-based quality measure are represented. |
||||
Copyright: | Example Copyright Statement |
||||
Disclaimer: | Example disclaimer |
||||
Basis: | Encounter | ||||
Scoring: |
Proportion |
||||
Type: |
process |
||||
Risk Adjustment: | Risk adjustment for this measure is performed by... | ||||
Rate Aggregation: | Rate aggregation for this measure is performed by... | ||||
Rationale: | Rationale for this measure is... |
||||
Clinical recommendation statement: | The clinical recommendation statement for this measure is... |
||||
Improvement Notation: |
Increased score indicates improvement |
||||
Guidance (Usage): | Users of this measure should be aware that this is intentionally simplified to show specific aspects of a measure. | ||||
Supplemental Data Elements: |
SDE Ethnicity SDE Race SDE Payer SDE Sex |
||||
Libraries: |
|